Related references
Note: Only part of the references are listed.The co-transfer of plasmid-borne colistin-resistant genes mcr-1 and mcr-3.5, the carbapenemase gene blaNDM-5 and the 16S methylase gene rmtB from Escherichia coli
Haiyan Long et al.
SCIENTIFIC REPORTS (2019)
Detection of the mcr-1 Colistin Resistance Gene in Carbapenem-Resistant Enterobacteriaceae from Different Hospitals in China
Hua Yu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study
S. S. Ahmed et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Zubair A. Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2015)
Task force on management and prevention of Acinetobacter baumannii infections in the ICU
Jose Garnacho-Montero et al.
INTENSIVE CARE MEDICINE (2015)
Risk Factors and Outcome Analysis of Acinetobacter baumannii Complex Bacteremia in Critical Patients*
Hao-Yuan Lee et al.
CRITICAL CARE MEDICINE (2014)
Risk factors for hospital-acquired pneumonia caused by carbapenem-resistant Gram-negative bacteria in critically ill patients: a multicenter study in Korea
Tark Kim et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Identification, Genotypic Relation, and Clinical Features of Colistin-Resistant Isolates of Acinetobacter Genomic Species 13BJ/14TU from Bloodstreams of Patients in a University Hospital
Seung Yeob Lee et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital
L. Silvia Munoz-Price et al.
CRITICAL CARE MEDICINE (2013)
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management
Jason M. Pogue et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2013)
Risk Factors for the First Episode of Klebsiella pneumoniae Resistant to Carbapenems Infection in Critically Ill Patients: A Prospective Study
Konstantinos Mantzarlis et al.
BIOMED RESEARCH INTERNATIONAL (2013)
CURRENT CONCEPTS Hospital-Acquired Infections Due to Gram-Negative Bacteria
Anton Y. Peleg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
Teresa C. Horan et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2008)
Acinetobacter baumannii:: Emergence of a successful pathogen
Anton Y. Peleg et al.
CLINICAL MICROBIOLOGY REVIEWS (2008)
Risk factors associated with the isolation of colistin-resistant Gyam-negative bacteria: A matched case-control study
Dimitrios K. Matthaiou et al.
CRITICAL CARE MEDICINE (2008)
Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections
Guelseren Baran et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2008)
Comparison of the host responses to wild-type and cpsB mutant Klebsiella pneumoniae infections
Matthew S. Lawlor et al.
INFECTION AND IMMUNITY (2006)
Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii
Jian Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Share Paper
